<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Half-sandwich Ir(III) and Os(II) complexes of pyridyl-mesoionic carbenes as potential anticancer agents</dc:title><dc:creator>Kralj,	Juran	(Avtor)
	</dc:creator><dc:creator>Bolje,	Aljoša	(Avtor)
	</dc:creator><dc:creator>Stupin Polančec,	Darija	(Avtor)
	</dc:creator><dc:creator>Steiner,	Ivana	(Avtor)
	</dc:creator><dc:creator>Gržan,	Tena	(Avtor)
	</dc:creator><dc:creator>Tupek,	Ana	(Avtor)
	</dc:creator><dc:creator>Stojanović,	Nikolina	(Avtor)
	</dc:creator><dc:creator>Hohloch,	Stephan	(Avtor)
	</dc:creator><dc:creator>Urankar,	Damijana	(Avtor)
	</dc:creator><dc:creator>Osmak,	Maja	(Avtor)
	</dc:creator><dc:creator>Sarkar,	Biprajit	(Avtor)
	</dc:creator><dc:creator>Brozović,	Anamaria	(Avtor)
	</dc:creator><dc:creator>Košmrlj,	Janez	(Avtor)
	</dc:creator><dc:subject>pyridyl-mesoionic carbenes</dc:subject><dc:subject>anticancer agents</dc:subject><dc:subject>iridium</dc:subject><dc:subject>osmium</dc:subject><dc:subject>cells</dc:subject><dc:subject>ligands</dc:subject><dc:subject>precursors</dc:subject><dc:subject>toxicity</dc:subject><dc:subject>transition metals</dc:subject><dc:description>A series of cationic chlorido arene-iridium(III) and arene-osmium(II) complexes with bidentate pyridyl functionalized mesoionic carbenes (MIC) of the 1,2,3-triazol-5-ylidene type have been prepared. The variations in the ligand structures include the position of the pyridyl substituent relative to the triazolylidene ring (N-wingtip vs C-wingtip), phenyl versus ethyl substituents, and incorporation of several functional groups at the phenyl substituents. Five complexes have been characterized by X-ray structural analysis. All complexes, including osmium(II) and ruthenium(II) analogues having a pyrimidyl in place of the pyridyl group, have been studied for their cytotoxic activity on a human cervical carcinoma HeLa cell line. Two of the compounds, Ir$^5$ and Ir$^9$, were the most cytotoxic with IC$_{50}$ values of 7.33 μM and 2.01 μM, respectively. Examination of their cytotoxic effect on different cell lines revealed that they preferentially kill cancer over normal cells. The Ir$^5$ and Ir$^9$ compounds arrested cells in G2 and induced a dose-dependent increase in SubG0/G1 cell population. Apoptosis, as the primary mode of cell death, was confirmed by Annexin V/PI staining, detection of cleaved PARP, and caspases 3 and 7 activity upon treatment of HeLa cells with both compounds. The higher toxicity of Ir$^9$ is probably due to its increased accumulation in the cells compared to Ir$^5$ . The role of glutathione (GSH) in the protection of cells against Ir$^5$ and Ir$^9$ cytotoxicity was confirmed by pretreatment of cells either with buthionine sulfoximine (inhibitor of GSH synthesis) or N-acetyl-cysteine (precursor in GSH synthesis).</dc:description><dc:date>2019</dc:date><dc:date>2022-10-17 10:33:46</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>142030</dc:identifier><dc:identifier>UDK: 547.79:546.9</dc:identifier><dc:identifier>ISSN pri članku: 0276-7333</dc:identifier><dc:identifier>DOI: 10.1021/acs.organomet.9b00327</dc:identifier><dc:identifier>COBISS_ID: 1538414787</dc:identifier><dc:language>sl</dc:language></metadata>
